Thousands in Florida to lose coverage for HIV meds because of state cuts

Thousands in Florida who rely on the AIDS Drug Assistance Program will see their coverage cut or their medication changed, ...
Seeking Alpha

Merck HIV therapy matches Gilead’s Biktarvy in late-stage trial

Merck (MRK) announced on Wednesday that its single-tablet antiviral regimen, doravirine and islatravir for adults with HIV, was found to be non-inferior to Gilead’s (GILD) once-daily HIV pill Biktarvy ...
Morningstar

ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain

In largest head-to-head randomized clinical trial evaluating the two medicines, Dovato (DTG/3TC) met the primary endpoint, demonstrating sustained non-inferior efficacy versus Biktarvy (BIC/FTC/TAF) ...